Form 4: Camp4 Therapeutics Corp: AH Equity Partners and Affiliates Report Beneficial Ownership Changes Following IPO

AH Equity Partners and related entities, including Marc Andreessen and Benjamin Horowitz, report changes in beneficial ownership of Camp4 Therapeutics Corp. common stock following the conversion of preferred stock in connection with the company's initial public offering.

Summary

• This Form 4 filing details changes in beneficial ownership of Camp4 Therapeutics Corp. (CAMP) stock by AH Equity Partners Bio I, L.L.C., AH Bio Fund I, L.P., AH Equity Partners Bio IV, L.L.C., AH Bio Fund IV, L.P., Marc Andreessen, and Benjamin Horowitz.
• The reported transactions occurred on October 15, 2024, and involve the conversion of Series A Prime Preferred Stock and Series B Preferred Stock into common stock at a ratio of 11.2158-for-one.
• AH Bio Fund I, L.P. acquired 1,398,067 shares of common stock through conversion and purchased 181,818 shares at $11 per share.
• AH Bio Fund IV, L.P. purchased 545,454 shares at $11 per share.
• Following these transactions, AH Bio Fund I, L.P. beneficially owns 1,579,885 shares, and AH Bio Fund IV, L.P. owns 545,454 shares.
• The filing clarifies that the reporting persons disclaim beneficial ownership of the securities held by AH Bio I and AH Bio IV, except to the extent of their pecuniary interest.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating standard post-IPO adjustments in share ownership. The sentiment is neutral to slightly positive as it reflects the completion of the IPO process.

Positives

• The conversion of preferred stock into common stock simplifies the company's capital structure following the IPO.

Industry Context

Form 4 filings are standard practice after an IPO, providing transparency regarding ownership changes by significant shareholders and insiders.

Stakeholder Impact

• Shareholders: Provides transparency regarding ownership structure post-IPO.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates